H.R. 5853 (112th): Gray Market Drug Reform and Transparency Act of 2012
May 22, 2012
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on May 22, 2012, in a previous session of Congress, but was not enacted.
Representative for Maryland's 7th congressional district
Read Text »
Last Updated: May 22, 2012
Length: 11 pages
About the bill
- Full Title
To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: May 14, 2013
- What is a bill?
The “H.R.” in “H.R. 5853” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr5853
“H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012.” www.GovTrack.us. 2012. April 25, 2015 <https://www.govtrack.us/congress/bills/112/hr5853>
|title=H.R. 5853 (112th)
|accessdate=April 25, 2015
|author=112th Congress (2012)
|date=May 22, 2012
|quote=Gray Market Drug Reform and Transparency Act of 2012